MAPT and Alzheimer disease: The original framework emphasized developmental and ASD-related mechanisms (Lammert and Howell, 2016); however, new evidence demonstrates that AD-related processes—Aβ, tau, and ApoE genotype—fit directly and mechanistically within this rheostat.